17-3658018-G-GC
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004937.3(CTNS):c.696dup(p.Val233ArgfsTer63) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,610,178 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R232R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004937.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CTNS | NM_004937.3 | c.696dup | p.Val233ArgfsTer63 | frameshift_variant | 10/12 | ENST00000046640.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CTNS | ENST00000046640.9 | c.696dup | p.Val233ArgfsTer63 | frameshift_variant | 10/12 | 1 | NM_004937.3 | P1 | |
CTNS-AS1 | ENST00000575741.1 | n.74_75insG | non_coding_transcript_exon_variant | 1/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250274Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135462
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1457924Hom.: 0 Cov.: 29 AF XY: 0.00000827 AC XY: 6AN XY: 725332
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152254Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74380
ClinVar
Submissions by phenotype
Nephropathic cystinosis Pathogenic:1Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Oct 27, 2023 | - - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
CTNS-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 28, 2024 | The CTNS c.696dupC variant is predicted to result in a frameshift and premature protein termination (p.Val233Argfs*63). This variant has been reported in the compound heterozygous and homozygous state in individuals with cystinosis and is also referred to as c.1035insC (Shotelersuk et al. 1998. PubMed ID: 9792862; Buntinx et al. 2016. PubMed ID: 27734949; Attard et al. 1999. PubMed ID: 10556299; Bengali et al. 2021. PubMed ID: 33661986). This variant is reported in 0.00088% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in CTNS are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Juvenile nephropathic cystinosis;C0950123:Inborn genetic diseases;C2931013:Ocular cystinosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 04, 2023 | This sequence change creates a premature translational stop signal (p.Val233Argfs*63) in the CTNS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTNS are known to be pathogenic (PMID: 9537412, 27102039). This variant is present in population databases (rs113994209, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with clinical features of nephropathic cystinosis (PMID: 9792862, 27734949). ClinVar contains an entry for this variant (Variation ID: 21441). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at